ATC's LADARVision PRK Laser Recommended For Approval
This article was originally published in The Gray Sheet
Autonomous Technologies Corp.'s LADARVision laser vision correction device provides superior post-operative uncorrected visual acuity to pre-operative best spectacle corrected visual acuity in approximately 20% of patients, according to data submitted by the Orlando, Florida-based firm in support of its September 1997 premarket approval application.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.